Abstract
3/2021
vol. 123
Review paper
Phytocannabinoids and the eye – a systematic review
- Division of Ophthalmology with the Children’s Ophthalmology Subunit, Stefan Żeromski Specialist Hospital in Krakow, Poland
- Department of Retinal and Vitreous Surgery, Medical University of Lublin, Poland
KLINIKA OCZNA 2021, 123, 3: 114–121
Online publish date: 2021/10/13
Recently, the use of marihuana for medical purposes has become more common. It can lead to many desired effects within the eye, as well as several adverse ones (i.a.: decrease in intraocular pressure, reduction of corneal pain and suppression of inflammation after chemical injury of cornea, treatment of blepharospasm, reduction of nystagmus, decrease in corneal endothelial cell density, eye irritation). There have not been enough studies with human subjects done on the safety and effectiveness of cannabis use in ophthalmology. Although synthetic cannabinoids combined with modulation of the endocannabinoid system might become the future of ophthalmology, more studies on this topic should be conducted.
Keywords
marijuana (marihuana), medical marijuana (marihuana), phytocannabinoids, Δ-9-tetrahydrocannabinol
Integrated with